OXOS Medical announced that its MC2 portable X-ray system received FDA 510(k) clearance, the agency's standard pathway for showing a device is as safe and effective as similar products already on the market, and is now available for sale. The wireless, cordless device includes a 9-inch detector with dynamic digital radiography and fluoroscopy, extending the ultra-portable X-ray line OXOS began with its Micro C system in 2021. CEO Evan Ruff said the clearance supports the company's goal of making radiographic imaging accessible outside traditional radiology rooms. OXOS Medical is a Parkway Venture Capital portfolio company.
Read the full article: OXOS Medical's announcement of MC2's FDA clearance
Share
Greatness lies ahead
Sign up for updates from the cutting edge of deep tech venture capital.
You’re on the list!
Something went wrong while submitting the form.





